Politico Morning e-Health
by Arthur Allen with help from David Pittman and Darius Tahir
October 30, 2017
…ATOM BOMB FOR DRUG DISCOVERY: A new open, sharable platform that combines high-powered computing and data shared from public and industry sources is designed to accelerate the discovery of new cancer drugs. The consortium behind the Accelerating Therapeutics for Opportunities in Medicine includes two national labs, drug giant GSK and the University of California, San Francisco. Their ambitious goal is to cut the time between when a drug target is spotted to a clinical candidate from roughly six years to one. “Although initially focused on precision oncology,” said Frederick National Laboratory for Cancer Research Director David Heimbrook, ”the consortium’s discoveries could accelerate drug discovery against many diseases”…
